Results 121 to 130 of about 13,660 (185)

Differences in disease burden between neuromyelitis optica spectrum disorder and multiple sclerosis in South China. [PDF]

Mult Scler J Exp Transl Clin
Huang X, Feng H, Li J, Fan Y, Zeng J.
europepmc   +1 more source

Epidemiology of neuromyelitis optica spectrum disease in Central-West Brazil: Prevalence and associated clinical and demographic features. [PDF]

Mult Scler J Exp Transl Clin
Balduino Nogueira NP, Deusdara Rodrigues RR, Cavalcante TB, Muniz Simões PL, Garces AG, Schoeps VA, de Lima PMP, Dias RM, Dos Santos LMB, Brum DG, von Glehn F.   +10 more
europepmc   +1 more source

Global landscape of neuromyelitis optica spectrum disorder clinical trials: trends in therapies, geography, and outcomes. [PDF]

Front Immunol
Wang G, Li J, Su X, Fang Z, Xu Y, Zheng J, Wang N, Huang L.   +7 more
europepmc   +1 more source

Pseudoathetotic Pseudodystonia as a Manifestation of Isolated Medullary Demyelination in Neuromyelitis Optica Spectrum Disorder. [PDF]

Tremor Other Hyperkinet Mov (N Y)
Mohapatra P, Hema LS, Mahadevan A, Garg D, Agarwal A, Pandit AK, Garg A, Srivastava AK, Radhakrishnan DM.   +8 more
europepmc   +1 more source

A case report: primary central nervous system lymphoma misdiagnosed as neuromyelitis optica. [PDF]

BMC Neurol
Zhang M, Liu X, Cheng S, Ruan Y.
europepmc   +1 more source

Cognitive Impairment and Quality of Life in AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study in Iranian Patients. [PDF]

Neurol Res Int
Ramazanzadeh S, Ashtari F.
europepmc   +1 more source

Satralizumab in the management of aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder during pregnancy: a case report. [PDF]

Front Immunol
Ding M, Yin B, Yao J, Liu Y, Dong H, Lu Z.   +5 more
europepmc   +1 more source

CXCL9 associates with experimental neuromyelitis optica spectrum disorder following adoptive transfer of Tfh and Th17 cells. [PDF]

Front Immunol
Wang L, Zhou L, Huang W, ZhangBao J, Tan H, Fan Y, Lu C, Yu J, Wang M, Lu J, Zhao C, Wang J, Quan C.   +12 more
europepmc   +1 more source

Granulocyte and astrocyte markers distinguish MOG-antibody disease and neuromyelitis optica from multiple sclerosis. [PDF]

Brain
Furlan R, Schaedelin S, Frederiksen JL, Watanabe M, Isobe N, Piehl F, Fink K, Iacobaeus E, Evertsson B, Khademi M, Gastaldi M, Greco G, Mariotto S, Carta S, Di Sapio A, Bava CI, Giorgi L, Benkert P, Maceski AM, Oechtering J, Willemse E, Pröbstel AK, Pröbstel AK, Pretzsch R, Finardi A, Mandelli A, Anthony DC, Kuhle J, Leppert D.   +28 more
europepmc   +1 more source

Biomarkers for satralizumab treatment in neuromyelitis optica spectrum disorders: a prospective case series. [PDF]

BMC Neurol
Hu S, Wang X, Wu H, Hong R, Xiao X, Zhao Y, Li R.   +6 more
europepmc   +1 more source